203 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Aug 22
Current report (foreign)
6:13am
individual’s previous dengue exposure.1 QDENGA has been generally well tolerated, with no important safety risks identified in the TIDES trial … , to date.6 Takeda recently presented long-term safety and efficacy results from the TIDES trial through 54 months of follow-up, which further validated
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
valuation 182,090 1,107,581 multipliers were applied to our financial, community -110 -289 -6,030 -2 spend, emissions, water use, and safety incident data … . Economic Economic Strategic Health Waste CO2 Water Social value value social & safety & air emissions Value retained offered invest- pollution
6-K
TAK
Takeda Pharmaceutical Co
21 May 21
Current report (foreign)
6:04am
Vaccine Moderna Intramuscular Injection) Following Positive Interim Results in Takeda’s Phase 1/2 Immunogenicity and Safety Clinical Trial
Interim … Phase 1/2 immunogenicity and safety clinical trial of Moderna’s COVID-19 vaccine in Japan, which showed an immune response consistent with results
6-K
TAK
Takeda Pharmaceutical Co
14 Oct 22
Current report (foreign)
7:36am
and Older in the EU and in Dengue-Endemic Countries Participating in the EU-M4all Procedure
Positive Opinion for TAK-003 Based on 4.5 Years of Safety … of a primary dengue vaccination in order to most accurately assess safety and efficacy.7 TIDES exploratory analyses showed that throughout the four
6-K
TAK
Takeda Pharmaceutical Co
1 Sep 21
Current report (foreign)
8:01am
3004667; and
An associated medical safety assessment, to determine if the identified particle poses a health or safety risk.
Root Cause Investigation … used in manufacturing and in food processing.
Current Medical Safety Assessment
After a health assessment conducted by Moderna and Takeda, the rare
6-K
ruwofgir7g
30 Oct 23
Current report (foreign)
6:02am
6-K
80qh 4rslnils65
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
x643avo 2f
18 Oct 23
Current report (foreign)
6:20am
6-K
fw47 bvlxsxc
13 Nov 23
Current report (foreign)
6:05am
6-K
EX-99.1
puogdzs7j04zpzbu
8 Dec 20
Current report (foreign)
6:01am
6-K
9yjkp10
16 Dec 21
Current report (foreign)
6:02am
6-K
27z9ym289 xytn6dlrsk
10 May 21
Current report (foreign)
6:06am
6-K
wyjq9vf988uantg zru
2 Feb 24
Current report (foreign)
6:16am
6-K
z81hfi
17 May 23
Current report (foreign)
6:02am
6-K
nksjw9
11 Sep 23
Current report (foreign)
6:50am
6-K
l2raeaad873a
4 Nov 22
Current report (foreign)
6:01am
6-K
ff3wv7
28 Sep 23
Current report (foreign)
6:17am
6-K
EX-99.1
44lp5hu7fy4qq
6 Apr 21
Current report (foreign)
6:29am
6-K
kjtmw 8bu1gp6hafw
24 Feb 21
Current report (foreign)
6:07am
6-K
EX-99.1
hitlisyuqq
17 Dec 20
Current report (foreign)
6:01am